Controversial Hydroxycut Class Action Have Already Been Filed
On May 1, 2009, there had been a recall of 14 Hydroxycut diet-aid products springing from a number of reports that folks using the products were developing serious liver problems and other health concerns. Less than seven days later, on May four, the 1st Hydroxycut class action lawsuit was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Case alleges company neglectfulness in informing the public about potential dangers of the products. Naturally, it’s too soon to understand the suit is going to turn out, but if the company had information which it did not reveal to buyers, it should definitely be held accountable.
A class action lawsuit is filed by a group of folk, all of whom have similar claims against a certain company. Filing a class action is just as effective, and far less expensive, than filing an individual suit. As a rule, filing a class action lawsuit won’t cost anything unless there is a settlement. At that point, the attorney who handled the suit will take his costs from the compensation that was given and then distribute the leftover funds to the litigants in the case. Since this is the case, you’ll be able to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is one of the explanations that class action lawsuits have become so popular.
The first class action lawsuit against Iovate was filed in Canada where the company is located and represents all Canadian voters who sustained health problems due to Hydroxycut products. The FDA recall occurred in the US where 23 cases of liver disorders and other health issues had been reported. Health Canada did not receive any reports of liver damage due to the diet products, but they did receive seventeen reports concerning folks who sustained respiration, neurological, cardio, and gut issues as a consequence of Canadians using the products.
The Hydroxycut Lawsuit alleges the company sold the company sold the products without properly informing the public of the health risks that they could exposing patrons to. The complaint states that the company did not publish the data on the product labels stating that users could run the risk of liver and kidney damage as well as stomach, heart, respiration, and neurological issues. The suit goes on to claim this was an obvious omission on the part of the company which deliberately misled clients concerning the security of the products.
